As the RGR peptide has been used for the tumor-targeted delivery of tumor necrosis factor α (Johansson et al., 2012), we attempted to improve the tumor-homing ability of TRAIL by fuzing RGR to the N-terminus of TRAIL (Figure 2(A)). This evidence concerns the gene TNF and neoplasm.